Skip to main content
Log in

Die gelernte Placeboantwort im Immunsystem

The learned placebo response in the immune system

  • Leitthema
  • Published:
Der Nervenarzt Aims and scope Submit manuscript

Zusammenfassung

Die gelernte Placeboantwort im Immunsystem basiert auf der wechselseitigen Interaktion zwischen Gehirn und Immunsystem; beide Systeme tauschen über humorale und neuronale Kommunikationswege beständig Informationen aus. Basierend auf diesem Kommunikationsnetzwerk lassen sich periphere Immunfunktionen mithilfe der klassischen oder pawlowschen Konditionierung entweder supprimieren oder stimulieren. Der vorliegende Beitrag gibt einen Überblick über tierexperimentelle Befunde, die auch die potenzielle klinische Relevanz der gelernten Immunantwort dokumentieren. Immunologische Reaktionen lassen sich auch beim Menschen mithilfe der klassischen Konditionierung modifizieren. Diese experimentellen Daten und klinischen Beobachtungen eröffnen die Perspektive, die gelernte Immunantwort als supportive Maßnahme zu immunpharmakologischen Behandlungsstrategien einzusetzen, um Medikamente und damit auch unerwünschte Nebenwirkungen einzusparen, bei gleichzeitiger Maximierung der therapeutischen Effekte.

Abstract

The learned placebo response of the immune system is based on the mutual interaction between the brain and the immune system; both systems continually exchange information via humoral and neural communication pathways. This communication network enables the modification, i.e. suppression or stimulation, of peripheral immune functions by classical or Pavlov’s conditioning. The present article provides an overview of the results of recent experimental animal studies, which also document the potential clinical relevance of learned immune responses. Learned immunological responses mediated by classical conditioning have also been demonstrated in humans. The knowledge gained from experimental data and clinical observations paves the way for a potential implementation of learned immune responses as supportive measures to standard immunopharmacological treatment strategies to reduce drug dosage as well as adverse side effects while simultaneously maximizing the therapeutic effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Ader R, Cohen N (1975) Behaviorally conditioned immunosuppression. Psychosom Med 37:333–340

    Article  CAS  Google Scholar 

  2. Ader R, Mercurio MG, Walton J et al (2010) Conditioned pharmacotherapeutic effects: a preliminary study. Psychosom Med 72:192–197

    Article  Google Scholar 

  3. Albring A, Wendt L, Benson S et al (2014) Preserving learned immunosuppressive placebo response: perspectives for clinical application. Int J Clin Pharmacol Ther 96:247–255

    Article  CAS  Google Scholar 

  4. Albring A, Wendt L, Benson S et al (2012) Placebo effects on the immune response in humans: the role of learning and expectation. Plos One 7:e49477

    Article  CAS  Google Scholar 

  5. Bingel U, Colloca L, Vase LJG (2011) Mechanisms and clinical implications of the placebo effect: is there a potential for the elderly? A mini-review. Gerontology 57:354–363

    Article  Google Scholar 

  6. Bosche K, Weissenborn K, Christians U et al (2015) Neurobehavioral consequences of small molecule-drug immunosuppression. Neuropharmacology 96:83–93

    Article  Google Scholar 

  7. De Mattos AM, Olyaei AJ, Bennett WM (2000) Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am J Kidney Dis 35:333–346

    Article  Google Scholar 

  8. Doering BK, Rief W (2012) Utilizing placebo mechanisms for dose reduction in pharmacotherapy. Trends Pharmacol Sci 33:165–172

    Article  CAS  Google Scholar 

  9. Enck P, Bingel U, Schedlowski M et al (2013) The placebo response in medicine: minimize, maximize or personalize? Nat Rev Drug Discov 12:191–204

    Article  CAS  Google Scholar 

  10. Exton MS, Gierse C, Meier B et al (2002) Behaviorally conditioned immunosuppression in the rat is regulated via noradrenaline and beta-adrenoceptors. J Neuroimmunol 131:21–30

    Article  CAS  Google Scholar 

  11. Exton MS, Schult M, Donath S et al (1999) Conditioned immunosuppression makes subtherapeutic cyclosporin effective via splenic innervation. Am J Physiol 276:R1710–1717

    CAS  PubMed  Google Scholar 

  12. Exton MS, Schult M, Donath S et al (1998) Behavioral conditioning prolongs heart allograft survival in rats. Transplant Proc 30:2033

    Article  CAS  Google Scholar 

  13. Goebel MU, Trebst AE, Steiner J et al (2002) Behavioral conditioning of immunosuppression is possible in humans. FASEB J 16:1869–1873

    Article  CAS  Google Scholar 

  14. Hadamitzky M, Bosche K, Wirth T et al (2016) Memory-updating abrogates extinction of learned immunosuppression. Brain Behav Immun 52:40–48

    Article  CAS  Google Scholar 

  15. Hadamitzky M, Luckemann L, Pacheco-Lopez G et al (2020) Pavlovian conditioning of immunological and neuroendocrine functions. Physiol Rev 100:357–405

    CAS  PubMed  Google Scholar 

  16. Halloran PF (2004) Immunosuppressive drugs for kidney transplantation. N Engl J Med 351:2715–2729

    Article  CAS  Google Scholar 

  17. Jabs DA, Rosenbaum JT, Foster CS et al (2000) Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 130:492–513

    Article  CAS  Google Scholar 

  18. Kahl AL, Kirchhof J, Petrakova L et al (2018) Are adverse events induced by the acute administration of calcineurin inhibitor cyclosporine a behaviorally conditioned in healthy male volunteers? Clin Ther 40:1868–1877

    Article  CAS  Google Scholar 

  19. Kirchhof J, Petrakova L, Brinkhoff A et al (2018) Learned immunosuppressive placebo responses in renal transplant patients. Proc Natl Acad Sci USA 115:4223–4227

    Article  CAS  Google Scholar 

  20. Klosterhalfen S, Klosterhalfen W (1990) Conditioned cyclosporine effects but not conditioned taste aversion in immunized rats. Behav Neurosci 104:716–724

    Article  CAS  Google Scholar 

  21. Klosterhalfen W, Klosterhalfen S (1983) Pavlovian conditioning of immunosuppression modifies adjuvant arthritis in rats. Behav Neurosci 97:663–666

    Article  CAS  Google Scholar 

  22. Longo DL, Duffey PL, Kopp WC et al (1999) Conditioned immune response to interferon-gamma in humans. Clin Immunol 90:173–181

    Article  CAS  Google Scholar 

  23. Lückemann L, Stangl H, Straub RH, Schedlowski M, Hadamitzky M (2019) Learned immunosuppressive placebo response attenuates disease progression in a rodent model of rheumatoid arthritis. Arthritis Rheumatol 72(4):588–597. https://doi.org/10.1002/art.41101

    Article  CAS  Google Scholar 

  24. Pacheco-Lopez G, Riether C, Doenlen R et al (2009) Calcineurin inhibition in splenocytes induced by pavlovian conditioning. FASEB J 23:1161–1167

    Article  CAS  Google Scholar 

  25. Pavlov VA, Tracey KJ (2017) Neural regulation of immunity: molecular mechanisms and clinical translation. Nat Neurosci 20:156–166

    Article  CAS  Google Scholar 

  26. Riether C, Kavelaars A, Wirth T et al (2011) Stimulation of beta(2)-adrenergic receptors inhibits calcineurin activity in CD4(+) T cells via PKA-AKAP interaction. Brain Behav Immun 25:59–66

    Article  CAS  Google Scholar 

  27. Schedlowski M, Enck P, Rief W et al (2015) Neuro-bio-behavioral mechanisms of placebo and nocebo responses: implications for clinical trials and clinical practice. Pharmacol Rev 67:697–730

    Article  Google Scholar 

  28. Schedlowski M, Pacheco-Lopez G (2010) The learned immune response: pavlov and beyond. Brain Behav Immun 24:176–185

    Article  Google Scholar 

  29. Tedesco D, Haragsim L (2012) Cyclosporine: a review. J Transplant. https://doi.org/10.1155/2012/230386

    Article  PubMed  PubMed Central  Google Scholar 

  30. Wirth T, Ober K, Prager G et al (2011) Repeated recall of learned immunosuppression: evidence from rats and men. Brain Behav Immun 25:1444–1451

    Article  CAS  Google Scholar 

  31. Wolf S (1959) The pharmacology of placebos

    Google Scholar 

  32. Wolf S (1950) Effects of suggestion and conditioning on the action of chemical agents in human subjects—the pharmacology of placebos. J Clin Invest 29:100–109

    Article  CAS  Google Scholar 

Download references

Förderung

Gefördert durch die Deutsche Forschungsgemeinschaft (DFG), TRR 289 Treatment Expectation, Projektnummer 422744262

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Schedlowski.

Ethics declarations

Interessenkonflikt

T. Hörbelt, S. Hetze, M. Schedlowski und L. Lückemann geben an, dass kein Interessenkonflikt besteht.

Alle nationalen Richtlinien zur Haltung und zum Umgang mit Labortieren wurden eingehalten und die notwendigen Zustimmungen der zuständigen Behörden liegen vor.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hörbelt, T., Hetze, S., Schedlowski, M. et al. Die gelernte Placeboantwort im Immunsystem. Nervenarzt 91, 667–674 (2020). https://doi.org/10.1007/s00115-020-00945-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00115-020-00945-6

Schlüsselwörter

Keywords

Navigation